From the data provided, the use of antihypertensive medicine in the Netherlands is stable with slight fluctuation. The Defined Daily Dosage (DDD) per thousand persons per day is expected to be 3.1 in 2024 and declines slightly to 3.0 from 2025 onwards. Year-on-year variation for 2025 is approximately -3.2%, with no further variation for the subsequent years of 2026 through 2028.
The future trend to watch includes potential advancements in hypertension management technologies and possible changes in healthcare policies. Additionally, shifts in population demographics and lifestyle changes may influence the long-term consumption patterns of antihypertensive medicines.
